Cargando…
Validating Differential Volatilome Profiles in Parkinson’s Disease
[Image: see text] Parkinson’s disease (PD) is a progressive neurodegenerative disorder that does not currently have a robust clinical diagnostic test. Nonmotor symptoms such as skin disorders have long since been associated with the disease, and more recently a characteristic odor emanating from the...
Autores principales: | Sinclair, Eleanor, Walton-Doyle, Caitlin, Sarkar, Depanjan, Hollywood, Katherine A., Milne, Joy, Lim, Sze Hway, Kunath, Tilo, Rijs, Anouk M., de Bie, Rob M. A., Silverdale, Monty, Trivedi, Drupad K., Barran, Perdita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908024/ https://www.ncbi.nlm.nih.gov/pubmed/33655068 http://dx.doi.org/10.1021/acscentsci.0c01028 |
Ejemplares similares
-
Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
por: Sinclair, Eleanor, et al.
Publicado: (2021) -
Discovery of Volatile Biomarkers of Parkinson’s
Disease from Sebum
por: Trivedi, Drupad K., et al.
Publicado: (2019) -
Paper Spray Ionization
Ion Mobility Mass Spectrometry
of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s
Disease
por: Sarkar, Depanjan, et al.
Publicado: (2022) -
Metabolomics for the masses: The future of metabolomics in a personalized world
por: Trivedi, Drupad K., et al.
Publicado: (2017) -
The untargeted urine volatilome for biomedical applications: methodology and volatilome database
por: Llambrich, Maria, et al.
Publicado: (2022)